AstraZeneca (AZN) Decline Tied to ONGLYZA FDA Briefing Docs
Tweet Send to a Friend
Declines pre-market in shares of AstraZeneca (NYSE: AZN) are tied to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE